Fluxome
Date | Investors | Amount | Round |
---|---|---|---|
- | N/A | - | |
$7.2m | Early VC | ||
€13.0m | Series B | ||
N/A | Grant | ||
N/A | Late VC | ||
N/A | Acquisition | ||
Total Funding | €19.5m |
Related Content
Recent News about Fluxome
EditFluxome operates in the biotechnology sector, specializing in the development and supply of nature-based flavors, fragrances, and health ingredients. The company serves a wide range of clients across various industries, including food and beverage, health and wellness, and personal care. Fluxome's business model revolves around the production and sale of high-quality, sustainable ingredients such as nootkatone, valencene, vanillin, and resveratrol. These ingredients are used in products that cater to the growing consumer demand for natural and health-conscious options. The company generates revenue through direct sales to manufacturers and businesses that incorporate these ingredients into their products. Fluxome's market is global, with a focus on regions with high growth potential. The company also offers tailored technology services to meet specific client needs, further diversifying its revenue streams.
Keywords: biotechnology, flavors, fragrances, health ingredients, nootkatone, valencene, vanillin, resveratrol, natural, sustainable.